Table 3. Antibiograms of all confirmed S. Enteritidis isolates tested against commonly used antibiotics in Jordan.
No. | Isolate ID | Antibiotic | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
AMa | CEF | CEP | CAZ | C | CIP | NA | SXT | Totald | ||
1 | 15b | I | S | R | S | S | S | I | R | 4 |
2 | 17b | R | R | R | S | S | R | R | S | 4 |
3 | 28b | S | S | S | S | S | R | R | S | 2 |
4 | 31b | S | S | S | S | S | R | R | S | 2 |
5 | 32b | S | S | S | S | S | R | R | S | 2 |
6 | 35b | S | S | S | S | S | R | R | S | 2 |
7 | 37b | R | S | R | S | S | I | R | S | 4 |
8 | 39b | R | I | I | S | R | R | R | S | 5 |
9 | 51b | I | S | R | S | S | S | R | S | 3 |
10 | 100b | R | S | R | S | S | I | R | S | 4 |
11 | 123b | R | R | I | S | R | R | R | I | 6 |
12 | 136b | R | I | I | S | R | R | R | S | 5 |
13 | 143b | R | I | I | S | R | R | R | S | 5 |
14 | 157b | R | I | I | S | R | R | R | S | 5 |
15 | 164b | R | S | S | S | S | R | R | R | 4 |
16 | 175b | R | R | R | S | R | R | R | I | 6 |
17 | 177b | R | I | S | S | R | R | R | S | 5 |
18 | 180b | R | R | I | S | R | R | R | S | 5 |
19 | Q1c | S | S | S | S | S | S | S | S | 0 |
20 | Q2c | S | I | S | S | S | S | S | S | 1 |
21 | Q3c | S | I | S | S | S | S | S | S | 1 |
22 | Q4c | R | R | R | S | S | S | R | S | 3 |
23 | Q5c | S | I | S | S | S | R | R | S | 3 |
24 | Q6c | S | S | S | S | S | S | S | S | 0 |
25 | Q7c | S | I | S | S | S | S | S | S | 1 |
a AM, ampicillin (penicillin family); CEF, cefoperazone (cephem family); CEP, cephalothin (cephem family); CAZ, ceftazidime (cephem family); C, chloramphenicol (phenicols family); CIP, ciprofloxacin (fluoroquinolones family); NA, nalidixic acid (quinolones family); SXT, sulphamethoxazone–trimethoprim (folate pathway inhibitors family); bpoultry isolates; chuman outbreak isolates; dtotal number of antibiotic families to which each isolate is exhibiting intermediate or full resistant.